文献速递脊柱脊髓外科

使用低分子量肝素预防脊柱手术后血栓栓塞并发症

Prevention of Thromboembolic Complications After Spine Surgery by the Use of Low-Molecular-Weight Heparin.
PubMed 文献 · World Neurosurg · 2017-05-18

该回顾性研究比较脊柱手术后每日治疗剂量低分子量肝素组(947例,2009年7月至2012年6月)与未用肝素对照组(814例,2006年7月至2009年6月),治疗组术后血栓栓塞并发症发生率低于对照组(0.21% vs 1.6%,P=0.002),出血并发症发生率两组差异边缘不显著(1.8% vs 0.74%,P=0.051)。

要点

  • 治疗组术后血栓栓塞并发症发生率为0.21%,低于对照组的1.6%(P=0.002)。
  • 脑梗死发生率下降最显著(P=0.005)。
  • 总体出血并发症治疗组1.8% vs 对照组0.74%,差异边缘不显著(P=0.051)。

核心结论

  • 使用低分子量肝素可显著降低脊柱手术后血栓形成和血栓栓塞并发症的发生率,但增加切口出血,导致症状性脊柱硬膜外血肿风险升高。

研究设计与样本

  • 回顾性研究,治疗组为2009年7月至2012年6月收治的947例脊柱手术患者,术后每日给予治疗剂量低分子量肝素;对照组为2006年7月至2009年6月收治的814例未接受任何肝素治疗的患者。

主要发现

  • 治疗组术后血栓栓塞并发症发生率为0.21%,对照组为1.6%(P=0.002)。
  • 在各类并发症中,脑梗死发生率的降低最显著(P=0.005)。
  • 总体出血并发症发生率治疗组为1.8%,对照组为0.74%,差异边缘不显著(P=0.051)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate the effectiveness and safety of the use of low-molecular-weight heparin (LMWH) in the prevention of thromboembolic complications after spine surgery. METHODS: We conducted a retrospective study on 2 groups of patients receiving spine surgery. A total of 947 patients admitted for surgery from July 2009 to June 2012 were administered therapeutic dose of LMWH daily after the surgery (therapeutic group). Another 814 patients enrolled from July 2006 to June 2009 were not given any heparin treatment (control group). The wound drainage volume, the incidence rate of thrombosis and thromboembolic complications, and the occurrence of bleeding complications in 2 groups were statistically compared. RESULTS: The therapeutic group showed a lower rate of postsurgery thromboembolic complications when compared with the control group (therapeutic group, 0.21%; control group, 1.6%; P = 0.002). Among the individual type of complications, the occurrence of cerebral infraction was the most significantly reduced (P = 0.005). The overall rate of bleeding complications was higher in the therapeutic group compared with the control group, and the difference was marginally insignificant (therapeutic group, 1.8%; control group, 0.74%; P = 0.051). CONCLUSIONS: The use of LMWH significantly decreases the incidence of thrombosis and thromboembolic complications after spine surgery, but increase the incision bleeding, leading to an elevated risk of symptomatic spinal epidural hematoma.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Zeng XJ, Peng H. Prevention of Thromboembolic Complications After Spine Surgery by the Use of Low-Molecular-Weight Heparin. World Neurosurg. 2017. PMID: 28529056. doi:10.1016/j.wneu.2017.05.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。